Co-transplantation of carotid body and ventral mesencephalic cells as an alternative approach towards functional restoration in 6-hydroxydopamine- lesioned rats: Implications for Parkinson's disease

Journal of Neurochemistry

Volumn 91, Issue 2, 2004, Pages 274-284

  Shukla, S ^a   Agrawal, A K ^a   Chaturvedi, R K ^a   Seth, K ^a   Srivastava, N ^b   Sinha, C ^a   Shukla, Y ^a   Khanna, V K ^a   Seth, P K ^a  

^a CSIR INDIAN INSTITUTE OF TOXICOLOGY RESEARCH   (India)

^b JIWAJI UNIVERSITY   (India)

Author keywords

6 hydroxydopamine; Carotid body; D amphetamine; Dopamine; Parkinson's disease; Tyrosine hydroxylase

Indexed keywords

3,4 DIHYDROXYPHENYLACETIC ACID; BRAIN DERIVED NEUROTROPHIC FACTOR; DEXAMPHETAMINE; DOPAMINE; DOPAMINE 2 RECEPTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; NEUROTROPHIC FACTOR; NEUROTROPHIN 3; OXIDOPAMINE; SPIPERONE; TRITIUM; TYROSINE 3 MONOOXYGENASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN CELL; CAROTID BODY; CELL SURVIVAL; CELL TRANSPLANTATION; CIRCLING BEHAVIOR; CONTROLLED STUDY; FEMALE; GLOMUS CELL; IMAGE ANALYSIS; IMMUNOHISTOCHEMISTRY; LOCOMOTION; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RECEPTOR BINDING; SCATCHARD PLOT; SUBSTANTIA NIGRA; VENTRAL MESENCEPHALIC CELL;

3,4-DIHYDROXYPHENYLACETIC ACID; ANIMALS; BINDING, COMPETITIVE; BRAIN TISSUE TRANSPLANTATION; CAROTID BODY; CAUDATE NUCLEUS; CELLS, CULTURED; DEXTROAMPHETAMINE; DISEASE MODELS, ANIMAL; DOPAMINE; FEMALE; GRAFT SURVIVAL; MESENCEPHALON; MOTOR ACTIVITY; OXIDOPAMINE; PARKINSONIAN DISORDERS; PUTAMEN; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D2; RECOVERY OF FUNCTION; TYROSINE 3-MONOOXYGENASE;

ANIMALIA; GLOMUS;

EID: 5444276658     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2004.02715.x     Document Type: Article

References (63)

1. Agrawal A. K., Squib R. E. and Bondy S. C. (1981) Effect of acrylamide treatment upon dopamine receptor binding. Toxicol. Appl. Pharmacol. 58, 89-99.
2. Ali M. M., Mathur N. and Chandra S. V. (1990) Effect of chronic cadmium exposure on locomotor activity of rats. Indian J. Exp. Biol. 28, 653-656.
3. Bohn M. C., Cupit L., Marciano F. and Gash D. M. (1987) Adrenal medulla grafts enhance recovery of striatal dopaminergic fibers. Science 237, 913-916.
4. Burnstein R. M., Foltynie T., He X., Menon D. K., Svendsen C. N. and Caldwell M. A. (2004) Differentiation and migration of long term expanded human neural progenitors in a partial lesion model of Parkinson's disease. Int. J. Biochem. Cell Biol. 36, 702-713.
5. Carman L. S., Gage F. H. and Shults C. W. (1991) Partial lesion of the substantia nigra: relation between extent of lesion and rotational behavior. Brain Res. 553, 275-283.
6. Chaturvedi R. K., Agrawal A. K., Seth K., Shukla S., Shukla Y., Sinha C. and Seth P. K. (2003) Effect of glial cell line derived neurotrophic factor (GDNF) co-transplantation with fetal ventral mesencephalic cells (VMC) on functional restoration in 6-hydroxydopamine (6-OHDA) lesioned rat model of Parkinson's disease: neurobehavioral, neurochemical and immunohistochemical studies. Int. J. Dev. Neurosci. 21, 391-400.
7. Chiang Y., Morales M., Zhou F. C., Borlongan C., Hoffer B. J. and Wang Y. (2001) Fetal intra-nigral ventral mesencephalon and kidney tissue bridge transplantation restores the nigrostriatal dopamine pathway in hemiparkinsonian rats. Brain Res. 889, 200-207.
8. Czyzyk-Krzeska M. F., Bayliss D. A., Lawson E. E. and Millhorn D. E. (1992) Regulation of tyrosine hydroxylase gene expression in the rat carotid body by hypoxia. J. Neurochem. 58, 1538-1546.
9. Dugan L. L., Lovett E. G., Quick K. L., Lotharius J., Lin T. T. and O'Malley K. L. (2001) Fullerene-based antioxidants and neurodegenerative disorders. Parkinsonism Relat. Disord. 7, 243-246.
10. Ehlers M. D., Kaplan D. R., Price D. L. and Koliatsos V. E. (1995) NGF-stimulated retrograde transport of trkA in the mammalian nervous system. J. Cell Biol. 130, 149-156.
11. Englund U., Bjorklund A. and Wictorin K. (2002) Migration patterns and phenotypic differentiation of long-term expanded human neural progenitor cells after transplantation into the adult brain. Dev. Brain Res. 134, 123-141.
12. Erickson J. T., Conover J. C., Borday V., Champagnat J., Barbacid M. and Yancopoulos G. (1996) Mice lacking brain-derived neurotrophic factor exhibit visceral sensory neuron losses distinct from mice lacking NT4 and display a severe developmental deficit in control of breathing. J. Neurosci. 16, 5361-5371.
13. Erickson J. T., Brosenitsch T. A. and Katz D. M. (2001) Brain-derived neurotrophic factor and glial cell line-derived factor are required simultaneously for survival of dopaminergic primary sensory neurons in vivo. J. Neurosci. 21, 581-589.
14. Espejo E. F., Montoro R. J., Armengol J. A. and Lopez-Barneo J. (1998) Cellular and functional recovery of Parkinsonian rats after intrastriatal transplantation of carotid body cell aggregates. Neuron 20, 197-206.
15. Fahn S. (2002) Results of the ELLDOPA (Earlier vs. Later Levodopa) Study. Mov. Disord. 17, S13.
16. Feng L., Wang C. Y., Jiang H., Oho C., Dugich-Djordjevic M., Mei L. and Lu B. (1999) Differential signaling of glial cell line-derived neurotrophic factor and brain-derived neurotrophic factor in cultured ventral mesencephalic neurons. Neuroscience 93, 265-273.
17. Freed W. J., Polterak N. and Becker J. B. (1990) Intracerebral adrenal medulla grafts: a review. Exp. Neural. 110, 139-166.
18. Freed C. R., Greene P. E., Breeze R. E. et al. (2001) Transplantation of embryonic dopamine neurons for severe Parkinson's disease. N. Engl. J. Med. 344, 710-719.
19. Freeman T. B., Sanberg P. R. and Nauert G. M. (1995) The influence of donor age on the survival of solid and suspension intraparenchymal human embryonic nigral grafts. Cell Transplant. 4, 141-154.
20. Gagnon C., Bedard P. J. and DiPaolo T. (1993) Grafts in the treatment of Parkinson's disease: animal models. Rev. Neurol. 4, 17-40.
21. Gash D. M., Zhang Z., Ovadia A. et al. (1996) Functional recovery in parkinsonian monkeys treated with GDNF. Nature 380, 252-255.
22. Granholm A.-C., Henry S., Hebert M. A., Eken S., Gerhardt G. A. and Home C. V. (1998) Kidney co-grafts enhance fiber outgrowth from ventral mesencephalic grafts to the 6-OHDA-lesioned striatum, and improve behavioral recovery. Cell Transplant. 7, 197-212.
23. Hansen J. T., Sakai K., Greenamyre J. T and Moran S. (1995) Sprouting of dopaminergic fibers from spared mesencephalic dopamine neurons in the unilateral partial lesioned rat. Brain Res. 670, 197-204.
24. Kearns C. M. and Gash D. M. (1995) GDNF protects nigral dopamine neurons against 6-hydroxydopamine in vivo. Brain Res. 672, 104-111.
25. Kordower J. H., Freeman T. B., Snow B. J. et al. (1995) Neuropathological evidence of graft survival and striatal reinnervation after the transplantation of fetal mesencephalic tissue in a patient with Parkinson's disease. N. Engl. J. Med. 332, 1118-1124.
26. Lang A. E. and Lozano A. M. (1998a) Parkinson's disease. First of two parts. N. Engl. J. Med. 339, 1044-1053.
27. Lang A. E. and Lozano A. M. (1998b) Parkinson's disease. Second of two parts. N. Engl. J. Med. 339, 1130-1143.
28. Lopez-Barneo J. (1996) Oxygen-sensing by ion channels and the regulation of cellular functions. Trends Neurosci. 19, 435-440.
29. Lowry O. H., Rosenburg N. J., Fair A. L. and Randall R. J. (1951) Protein measurement by Folin phenol reagent. J. Biol. Chem. 193, 165-175.
30. Luquin M. R., Montoro R. J., Guillen J., Saldise L., Insausti R., Del Rio J. and Lopez-Barneo J. (1999) Recovery of chronic Parkinsonian monkey by autotransplants of carotid body cell aggregates into putamen. Neuron 22, 743-750.
31. Marek K., Jennings D. and Seibyl J. (2002) Do dopamine agonists or levodopa modify Parkinson's disease progression? Eur. J. Neurol. 9, 15-22.
32. Matsuo A., Nakamura S. and Akiguchi I. (2000) Immunohistochemical localization of glial cell line-derived neurotrophic factor family receptor α-1 in the rat brain: confirmation of expression in various neuronal systems. Brain Res. 859, 57-71.
33. McGrath J., Lintz E., Hoffer B. J., Gerhardt G. A., Quintero E. M. and Granholm A. C. (2002) Adeno-associated viral delivery of GDNF promotes recovery of dopaminergic phenotype following a unilateral 6-hydroxydopamine lesion. Cell Transplant. 11, 215-227.
34. Montoro R. J., Urena J., Fernandez-Chacon R., Alvarez de Toledo G. and Lopez-Barneo J. (1996) Oxygen sensing by ion channels and chemotransduction in single glomus cells. J. Gen. Physiol. 107, 133-143.
35. Mufson E. J., Kroin J. S., Sendera T. J. and Sobreviela T. (1999) Distribution and retrograde transport of trophic factors in the central nervous system: Functional implications for the treatment of neurodegenerative diseases. Prog. Neurobiol. 57, 451-484.
36. Nakao N., Frodl E. M., Duan W. M., Widner H. and Brundin P. (1994) Lazaroids improve the survival of grafted rat embryonic dopamine neurons. Proc. Natl Acad. Sci. USA 91, 12408-12412.
37. Nikkhah G., Olsson M., Eberhard J., Bentlage C., Cunningham M. G. and Bjorklund A. (1994) A microtransplantation approach for cell suspension grafting in the rat Parkinson model: a detailed account of the methodology. Neuroscience 63, 57-72.
38. Nosrat C. A., Tomac A., Lindskog S., Humpel C., Stromberg I., Ebendal T., Hoffer B. and Olson L. (1996) Cellular expression of GDNF mRNA suggests multiple functions inside and outside the nervous system. Cell Tissue Rex. 286, 191-207.
39. Nurse C. A. and Vollmer C. (1997) Role of basic FGF and oxygen in control of proliferation, survival, and neuronal differentiation in carotid body chromaffin cells. Dev. Biol. 184, 197-206.
40. Olsson M., Bentlage C., Wictorin K., Campbell K. and Bjorklund A. (1997) Extensive migration and target innervation by striatal precursors after grafting into the neonatal striatum. Neuroscience 79, 57-78.
41. Palfi S., Leventhal L., Chu Y., Ma S. Y., Emborg M., Bakay R., Deglon N., Hantraye P., Aebischer P. and Kordower J. H. (2002) Lentivirally delivered glial cell line-derived neurotrophic factor increases the number of striatal dopaminergic neurons in primate models of nigrostriatal degeneration. J. Neurosci. 22, 4942-4954.
42. Paxinos G. and Watson C., eds. (1998) The Rat Brain in Stereotaxic Coordinates, 4th edn. Academic Press, California, USA.
43. Pearse A. G. E., Polak J. M., Rost F. W. D., Fontaine J., Le Lievre C. and Le Dourain N. (1973) Demonstration of the neural crest origin of type 1 (APUD) cells in the avian carotid body using a cytochemical marker system. Histochemie 34, 191-203.
44. Pochon N. A. M., Menoudseng J. L., Zurn A. D. and Aebischer P. (1997) Neuronal GDNF expression in the adult rat nervous system identified by in situ hybridization. Eur. J. Neurosci. 9, 463-471.
45. Rosenblad C., Martinez-Serrano A. and Bjorklund A. (1998) Intrastriatal glial cell-line derived neurotrophic factor promotes sprouting of spared nigrostriatal dopaminergic afferents and induces recovery of function in a rat model of Parkinson's disease. Neuroscience 82, 129-137.
46. Rosenblad C., Kirik D. and Bjorklund A. (1999) Neurturin enhances the survival of intrastriatal fetal dopaminergic transplants. Neuroreport 10, 1783-1787.
47. Sanberg P. R., Borlongan C. V., Othberg A. I., Saporta S., Freeman T. B. and Cameron D. F. (1997) Testis-derived Sertoli cells have a trophic effect on dopamine neurons and alleviate hemiparkinsonism in rats. Nat. Med. 3, 1129-1132.
48. Sautter J., Tseng J. L., Braguglia D., Aebischer P., Spenger C., Seiler R. W., Widmer H. R. and Zurn A. D. (1998) Implants of polymer-encapsulated genetically modified cells releasing glial cell line-derived neurotrophic factor improve survival, growth, and function of fetal dopaminergic grafts. Exp. Neurol. 149, 230-236.
49. Scatchard G. (1949) The alteration of protein for small molecules and ions. Ann. N.Y. Acad. Sci. 51, 660-672.
50. Schierle S. G., Hansson O., Leist M., Nicotera P., Widner H. and Brundin. P. (1999) Caspase inhibition reduces apoptosis and increases survival of nigral transplants. Nat. Med. 5, 97-100.
51. Schwarting R. K. W. and Huston J. P. (1996) The unilateral 6-hydroxydopamine lesion model in behavioral brain research: analysis of functional deficits, recovery and treatments. Prog. Neurobiol. 50, 275-331.
52. 2 chemoreceptors by chronic hypoxia and cyclic AMP in vivo. J. Neurosci. 15, 2192-2202.
53. Takayama H., Ray J., Raymon H. K., Baird A., Hogg J., Fisher L. J. and Gage F. H. (1995) Basic fibroblast growth factor increases dopaminergic graft survival and function in a rat model of Parkinson's disease. Nat. Med. 1, 53-58.
54. Toledo-Aral J. J., Mendez-Ferrer S., Pardal R. and Echevarria. & Lopez-Barneo J. (2003) Trophic restoration of the nigrostriatal dopaminergic pathway in long term carotid body-grafted parkinsonian rats. J. Neurosci. 23, 141-148.
55. Tomac A., Widenfalk J., Lin L. H., Kohno T., Ebendal T., Hoffer J. B. and Olson L. (1995) Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult. Proc. Natl Acad. Sci. USA 92, 8274-8278.
56. Ungerstedt U. (1971) Striatal dopamine release after amphetamine or nerve degeneration revealed by rotational behaviour. Acta Physiol. Scand. 367, 49-68.
57. Ungerstedt U. and Arbuthnott G. W. (1970) Quantitative recording of rotational behavior in rats after 6-hydroxy-dopamine lesions of the nigrostriatal dopamine system. Brain Res. 24, 485-493.
58. 2+ entry and quantal dopamine secretion in carotid body glomus cells. Proc. Natl Acad. Sci. USA 91, 10208-10211.
59. Wang L., Muramatsu S., Lu Y. et al. (2002) Delayed delivery of AAV-GDNF prevents nigral neurodegeneration and promotes functional recovery in a rat model of Parkinson's disease. Gene Ther. 9, 381-389.
60. Wenning G. K., Granata R., Laboyrie P. M., Quinn N. P., Jenner P. and Marsden C. D. (1996) Reversal of behavioral abnormalities by fetal allografts in a novel rat model of striatonigral degeneration. Mov. Disord. 11, 522-532.
61. Yoshida H., Date I., Shingo T., Fujiwara K., Kobayashi K., Miyoshi Y. and Ohmoto T. (2003) Stereotactic transplantation of a dopamine-producing capsule into the striatum for treatment of Parkinson disease: a preclinical primate study. J. Neurosurg. 98, 874-881.
62. Yoshimoto Y., Lin Q., Collier T. J., Frim D. M., Breakefield X. O. and Bohn M. C. (1995) Astrocytes retrovirally transduced with BDNF elicit behavioral improvement in a rat model of Parkinson's disease. Brain Res. 691, 25-36.
63. Yurek D. M., Lu W., Hipkens S. and Wiegand S. J. (1996) BDNF enhances the functional reinnervation of the striatum by grafted fetal dopamine neurons. Exp. Neurol. 137, 105-118.